74 related articles for article (PubMed ID: 9881463)
21. Phenotypic and molecular epidemiology of Acinetobacter baumannii strains isolated in Rabta Hospital, Tunisia.
Ben Othman A; Zribi M; Masmoudi A; Abdellatif S; Ben Lakhal S; Fendri C
Arch Inst Pasteur Tunis; 2007; 84(1-4):11-9. PubMed ID: 19388579
[TBL] [Abstract][Full Text] [Related]
22. Clonal spread of Acinetobacter baumannii in a general intensive care unit.
Marroni M; Pasquarella C; Agodi A; Nnanga N; Barchitta M; Prattichizzo L; Fiorio M; Bulletti M; Dentini N; Baldelli F; Stefani S; Savino A; Stagni G
Ann Ig; 2004; 16(1-2):95-102. PubMed ID: 15554515
[TBL] [Abstract][Full Text] [Related]
23. Synthetic multimeric heptyl mannosides as potent antiadhesives of uropathogenic Escherichia coli.
Gouin SG; Wellens A; Bouckaert J; Kovensky J
ChemMedChem; 2009 May; 4(5):749-55. PubMed ID: 19343765
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact and pathogenicity of Acinetobacter.
Joly-Guillou ML
Clin Microbiol Infect; 2005 Nov; 11(11):868-73. PubMed ID: 16216100
[TBL] [Abstract][Full Text] [Related]
25. Spread of multidrug resistant Acinetobacter baumannii in a teaching hospital.
Hammami S; Ghozzi R; Ben Redjeb S
Tunis Med; 2008 Apr; 86(4):312-5. PubMed ID: 19476129
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
[TBL] [Abstract][Full Text] [Related]
27. Virulence factors in uropathogenic E. coli.
Shrikhande SN; Chande CA; Pathak AA
Indian J Pathol Microbiol; 1999 Jul; 42(3):321-5. PubMed ID: 10862292
[TBL] [Abstract][Full Text] [Related]
28. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
29. [Sensitivity to blood bactericidal activity and hydrophobicity of Acinetobacter baumannii after treatment with imipenem].
Hostacká A
Epidemiol Mikrobiol Imunol; 1999 Apr; 48(2):67-70. PubMed ID: 10349782
[TBL] [Abstract][Full Text] [Related]
30. Drug-resistant gene based genotyping for Acinetobacter baumannii in tracing epidemiological events and for clinical treatment within nosocomial settings.
Jin H; Xu XM; Mi ZH; Mou Y; Liu P
Chin Med J (Engl); 2009 Feb; 122(3):301-6. PubMed ID: 19236808
[TBL] [Abstract][Full Text] [Related]
31. [Expression of Class I integrase gene in Acinetobacter baumannii and drug-resistance].
Li L; Xia ZD; Hu ZH; Zhou ZQ; Li HT
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):952-7. PubMed ID: 19001740
[TBL] [Abstract][Full Text] [Related]
32. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A
J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
[TBL] [Abstract][Full Text] [Related]
33. Relationship between antimicrobial resistance and aminoglycoside-modifying enzyme gene expressions in Acinetobacter baumannii.
Shi WF; Jiang JP; Mi ZH
Chin Med J (Engl); 2005 Jan; 118(2):141-5. PubMed ID: 15667800
[TBL] [Abstract][Full Text] [Related]
34. [Multidrug resistant Acinetobacter baumannii].
Nemec A
Klin Mikrobiol Infekc Lek; 2008 Oct; 14(5):162-7. PubMed ID: 19051163
[TBL] [Abstract][Full Text] [Related]
35. [Transmission and molecular characteristics of carbapenem-resistant Acinetobacter baumannii].
Wei X; Shen DX; Yan ZQ; Luo YP; Cao JR
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Mar; 29(3):277-81. PubMed ID: 18788529
[TBL] [Abstract][Full Text] [Related]
36. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.
Wroblewska MM; Towner KJ; Marchel H; Luczak M
Clin Microbiol Infect; 2007 May; 13(5):490-6. PubMed ID: 17331123
[TBL] [Abstract][Full Text] [Related]
37. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
[TBL] [Abstract][Full Text] [Related]
38. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study.
Apisarnthanarak A; Pinitchai U; Thongphubeth K; Yuekyen C; Warren DK; Fraser VJ;
Clin Infect Dis; 2008 Sep; 47(6):760-7. PubMed ID: 18684100
[TBL] [Abstract][Full Text] [Related]
39. Effect of EDTA on the resistance of clinical isolates of Acinetobacter baumannii to the bactericidal activity of normal human serum.
García A; Solar H; González C; Zemelman R
J Med Microbiol; 2000 Nov; 49(11):1047-1050. PubMed ID: 11073160
[TBL] [Abstract][Full Text] [Related]
40. Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis.
Cetin ES; Durmaz R; Tetik T; Otlu B; Kaya S; Calişkan A
Am J Infect Control; 2009 Feb; 37(1):56-64. PubMed ID: 18834735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
